Guidelines for the diagnosis and treatment of chronic heart failure:: executive summary (update 2005)

被引：1651

作者：

Swedberg, K ^{[1
]}

Cleland, J ^{[1
]}

Dargie, H ^{[1
]}

Drexler, H ^{[1
]}

Follath, F ^{[1
]}

Komajda, M ^{[1
]}

Tavazzi, L ^{[1
]}

Smiseth, OA ^{[1
]}

Gavazzi, A ^{[1
]}

Haverich, A ^{[1
]}

Hoes, A ^{[1
]}

Jaarsma, T ^{[1
]}

Korewicki, J ^{[1
]}

Lévy, S ^{[1
]}

Linde, C ^{[1
]}

Lopez-Sendon, JL ^{[1
]}

Nieminen, MS ^{[1
]}

Piérard, L ^{[1
]}

Remme, WJ ^{[1
]}

机构：

[1] Univ Gothenburg, Sahlgrenska Univ Hosp Ostra, Sahlgrenska Acad, Dept Med, SE-41685 Gothenburg, Sweden

来源：

EUROPEAN HEART JOURNAL | 2005年 / 26卷 / 11期

关键词：

D O I：

10.1093/eurheartj/ehi204

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1115 / 1140

页数：26

共 167 条

[51] Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction [J].

Dries, DL ;

Sweitzer, NK ;

Drazner, MH ;

Stevenson, LW ;

Gersh, BJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :421-428

[52] Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure - The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators [J].

Dunselman, PHJM .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 77 (2-3) :131-138

[53]

Eichhorn E, 2001, NEW ENGL J MED, V344, P1659

[54] Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure [J].

Ekman, I ;

Andersson, B ;

Ehnfors, M ;

Matejka, G ;

Persson, B ;

Fagerberg, B .

EUROPEAN HEART JOURNAL, 1998, 19 (08) :1254-1260

[55] A standardized definition of ischemic cardiomyopathy for use in clinical research [J].

Felker, GM ;

Shaw, LK ;

O'Connor, CM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :210-218

[56] FASTTRACK Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) [J].

Flather, MD ;

Shibata, MC ;

Coats, AJS ;

Van Veldhuisen, DJ ;

Parkhomenko, A ;

Borbola, J ;

Cohen-Solal, A ;

Dumitrascu, D ;

Ferrari, R ;

Lechat, P ;

Soler-Soler, J ;

Tavazzi, L ;

Spinarova, L ;

Toman, J ;

Böhm, M ;

Anker, SD ;

Thompson, SG ;

Poole-Wilson, PA .

EUROPEAN HEART JOURNAL, 2005, 26 (03) :215-225

[57] Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients [J].

Flather, MD ;

Yusuf, S ;

Kober, L ;

Pfeffer, M ;

Hall, A ;

Murray, G ;

Torp-Pedersen, C ;

Ball, S ;

Pogue, J ;

Moyé, L ;

Braunwald, E .

LANCET, 2000, 355 (9215) :1575-1581

[58] Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial [J].

Follath, F ;

Cleland, JGF ;

Just, H ;

Papp, JGY ;

Scholz, H ;

Peuhkurinen, K ;

Harjola, VP ;

Mitrovic, V ;

Abdalla, M ;

Sandell, EP ;

Lehtonen, L .

LANCET, 2002, 360 (9328) :196-202

[59] Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure [J].

Ghio, S ;

Gavazzi, A ;

Campana, C ;

Inserra, C ;

Klersy, C ;

Sebastiani, R ;

Arbustini, E ;

Recusani, F ;

Tavazzi, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :183-188

[60] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial [J].

Granger, CB ;

McMurray, JJV ;

Yusuf, S ;

Held, P ;

Michelson, EL ;

Olofsson, B ;

Östergren, J ;

Pfeffer, MA ;

Swedberg, K .

LANCET, 2003, 362 (9386) :772-776

← 1 2 3 4 5 6 7 8 9 10 →